Observational Study of Pituitary Tumors
This study is observing people with pituitary tumors to understand what causes them to come back and what signs show the disease is still active. There are no specific interventions (like drugs or treatments) being tested; instead, researchers are collecting information about your health, treatments, and outcomes. You can join if you are 18 years or older and have a confirmed pituitary disease. The main goal is to see how long people live (longevity) over 20 years. The current status of this study is unclear, but it plans to enroll about 1250 participants.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to include about 1250 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 20 years to measure overall survival (longevity).
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pituitary Tumor Surveillance: Pathogenic Correlation
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Shlomo Melmed, MD · PRINCIPAL_INVESTIGATOR · Cedars-Sinai Medical Center, Pituitary Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Overall Survival (Longevity)20 years
Overall survival will be measured from study enrollment (or diagnosis, as applicable) to death from any cause. Survival status will be determined through electronic medical records and, if necessary, supplemented by publicly available death records (e.g., National Death Index).